S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

Elevance Health (ELV) Stock Price, News & Analysis

$531.42
+6.23 (+1.19%)
(As of 04/19/2024 ET)
Today's Range
$525.90
$536.05
50-Day Range
$497.60
$531.59
52-Week Range
$412.00
$539.11
Volume
1.79 million shs
Average Volume
1.02 million shs
Market Capitalization
$123.66 billion
P/E Ratio
20.08
Dividend Yield
1.23%
Price Target
$584.50

Elevance Health MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.92 Rating Score
Upside/​Downside
10.0% Upside
$584.50 Price Target
Short Interest
Healthy
0.90% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.86mentions of Elevance Health in the last 14 days
Based on 52 Articles This Week
Insider Trading
Selling Shares
$376,500 Sold Last Quarter
Proj. Earnings Growth
11.45%
From $37.20 to $41.46 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.18 out of 5 stars

Medical Sector

140th out of 911 stocks

Hospital & Medical Service Plans Industry

6th out of 11 stocks

ELV stock logo

About Elevance Health Stock (NYSE:ELV)

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

ELV Stock Price History

ELV Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Elevance Health (ELV) Q1 2024 Earnings Call Transcript
Elevance Health declares $1.63 dividend
Elevance Health (NYSE:ELV) Shares Gap Up to $500.09
Elevance Health Reports First Quarter 2024 Results
See More Headlines
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/22 Dividend
3/07/2024
Dividend Payable
3/22/2024
Last Earnings
4/18/2024
Today
4/20/2024
Next Earnings (Estimated)
7/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Managed Health Care
CUSIP
94973V10
Employees
104,900
Year Founded
2004

Price Target and Rating

Average Stock Price Target
$584.50
High Stock Price Target
$621.00
Low Stock Price Target
$550.00
Potential Upside/Downside
+10.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
13 Analysts

Profitability

Net Income
$5.99 billion
Pretax Margin
4.68%

Debt

Sales & Book Value

Annual Sales
$171.34 billion
Cash Flow
$41.75 per share
Book Value
$174.95 per share

Miscellaneous

Free Float
231,886,000
Market Cap
$123.66 billion
Optionable
Optionable
Beta
0.78

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Ms. Gail Koziara Boudreaux (Age 63)
    President, CEO & Director
    Comp: $6.09M
  • Mr. Mark Bradley Kaye (Age 44)
    Executive VP & CFO
    Comp: $659.18k
  • Mr. Blair Williams Todt (Age 56)
    EVP, Chief Legal & Administrative Officer
    Comp: $2.11M
  • Mr. Peter David Haytaian Esq. (Age 54)
    Executive VP and President of Carelon & CarelonRx
    Comp: $2.68M
  • Ms. Felicia Farr Norwood (Age 64)
    Executive VP & President of Government Health Benefits
    Comp: $2.18M
  • Mr. Scott Wayne Anglin
    SVP, Treasurer & Chief Investment Officer
  • Mr. Ronald William Penczek (Age 59)
    Senior VP, Controller & Chief Accounting Officer
  • Mr. Anil Bhatt
    Chief Information Officer
  • Mr. Stephen Vartan Tanal C.F.A.
    Vice President of Investor Relations
  • Ms. Julie Goon
    Senior Vice President of Public Affairs

ELV Stock Analysis - Frequently Asked Questions

Should I buy or sell Elevance Health stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elevance Health in the last year. There are currently 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ELV shares.
View ELV analyst ratings
or view top-rated stocks.

What is Elevance Health's stock price target for 2024?

13 Wall Street analysts have issued 12 month price targets for Elevance Health's shares. Their ELV share price targets range from $550.00 to $621.00. On average, they predict the company's stock price to reach $584.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price.
View analysts price targets for ELV
or view top-rated stocks among Wall Street analysts.

How have ELV shares performed in 2024?

Elevance Health's stock was trading at $471.56 at the start of the year. Since then, ELV stock has increased by 12.7% and is now trading at $531.42.
View the best growth stocks for 2024 here
.

Are investors shorting Elevance Health?

Elevance Health saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 2,090,000 shares, a decline of 10.7% from the March 15th total of 2,340,000 shares. Based on an average trading volume of 1,020,000 shares, the short-interest ratio is currently 2.0 days. Currently, 0.9% of the shares of the stock are sold short.
View Elevance Health's Short Interest
.

When is Elevance Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 17th 2024.
View our ELV earnings forecast
.

How were Elevance Health's earnings last quarter?

Elevance Health, Inc. (NYSE:ELV) announced its earnings results on Thursday, April, 18th. The company reported $10.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.54 by $0.10. The business earned $42.27 billion during the quarter, compared to the consensus estimate of $42.49 billion. Elevance Health had a net margin of 3.64% and a trailing twelve-month return on equity of 20.62%. The business's revenue was up .9% on a year-over-year basis. During the same period last year, the firm posted $9.46 EPS.

How often does Elevance Health pay dividends? What is the dividend yield for Elevance Health?

Elevance Health announced a quarterly dividend on Friday, April 19th. Shareholders of record on Monday, June 10th will be paid a dividend of $1.63 per share on Tuesday, June 25th. This represents a $6.52 annualized dividend and a yield of 1.23%. The ex-dividend date is Monday, June 10th.
Read our dividend analysis for ELV
.

Is Elevance Health a good dividend stock?

Elevance Health (NYSE:ELV) pays an annual dividend of $6.52 per share and currently has a dividend yield of 1.24%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 24.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ELV will have a dividend payout ratio of 15.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ELV.

What guidance has Elevance Health issued on next quarter's earnings?

Elevance Health updated its FY 2024 earnings guidance on Friday, March, 15th. The company provided earnings per share guidance of 37.100- for the period, compared to the consensus EPS estimate of 37.150. The company issued revenue guidance of -.

Who are Elevance Health's major shareholders?

Elevance Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.36%), Perpetual Ltd (0.22%), Global Assets Advisory LLC (0.09%), Los Angeles Capital Management LLC (0.06%), Gateway Investment Advisers LLC (0.04%) and Allspring Global Investments Holdings LLC (0.04%). Insiders that own company stock include Charles Morgan Kendrick Jr, Gloria M Mccarthy, John E Gallina, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Ryan M Schneider.
View institutional ownership trends
.

How do I buy shares of Elevance Health?

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Elevance Health have any subsidiaries?
The following companies are subsidiares of Elevance Health: 1-800 Contacts, AIM Specialty Health, AMERIGROUP Community Care of New Mexico Inc., AMERIGROUP Corporation, AMERIGROUP Maryland Inc., AMERIGROUP New Jersey Inc., AMERIGROUP Ohio Inc., AMERIGROUP Tennessee Inc., AMERIGROUP Texas Inc., AMERIGROUP Washington Inc., AMGP Georgia Managed Care Company Inc., ATH Holding Company LLC, America's 1st Choice of South Carolina Inc., America's Health Management Services Inc., American Imaging Management Inc., America’s 1st Choice, Amerigroup, Amerigroup Delaware Inc., Amerigroup District of Columbia Inc., Amerigroup Health Plan of Louisiana Inc., Amerigroup IPA of New York LLC, Amerigroup Insurance Company, Amerigroup Iowa Inc., Amerigroup Kansas Inc., Amerigroup Mississippi Inc., Amerigroup Oklahoma Inc., Amerigroup Partnership Plan LLC, Amerigroup Pennsylvania Inc., Anthem Blue Cross Life and Health Insurance Company, Anthem Financial Inc., Anthem Health Plans Inc., Anthem Health Plans of Kentucky Inc., Anthem Health Plans of Maine Inc., Anthem Health Plans of New Hampshire Inc., Anthem Health Plans of Virginia Inc., Anthem Holding Corp., Anthem Innovation Israel Ltd., Anthem Insurance Companies Inc., Anthem Kentucky Managed Care Plan Inc., Anthem Life & Disability Insurance Company, Anthem Life Insurance Company, Anthem Partnership Holding Company LLC, Anthem Services Company LLC, Anthem Southeast Inc., Anthem UM Services Inc., Anthem Workers' Compensation LLC, Applied Pathways LLC, Arcus Enterprises Inc., Aspire Health Inc., Aspire Healthcare Corp, Associated Group Inc., Beacon Health Options, Blue Cross Blue Shield Healthcare Plan of Georgia Inc., Blue Cross Blue Shield of Wisconsin, Blue Cross of California, Blue Cross of California Partnership Plan Inc., CareMarket Inc., CareMore Health Plan, CareMore Health Plan of Arizona Inc., CareMore Health Plan of Nevada, CareMore Health Plan of Texas Inc., CareMore Health System, CareMore LLC, Cerulean Companies Inc., Claim Management Services Inc., Community Care Health Plan of Louisiana Inc., Community Care Health Plan of Nevada Inc., Community Insurance Company, Compcare Health Services Insurance Corporation, Crossroads Acquisition Corp., DBG Holdings Inc., DeCare Analytics LLC, DeCare Dental Health International LLC, DeCare Dental Insurance Ireland Ltd., DeCare Dental LLC, DeCare Dental Networks LLC, DeCare Operations Ireland Limited, Delivery Network LLC, Designated Agent Company Inc., EHC Benefits Agency Inc., EasyScripts Cutler Bay LLC, EasyScripts Hialeah LLC, EasyScripts LLC, EasyScripts Westchester LLC, Empire HealthChoice Assurance Inc., Empire HealthChoice HMO Inc., Federal Government Solutions LLC, Freedom Health Inc., Global TPA LLC, Golden West Health Plan Inc., Greater Georgia Life Insurance Company, HEP AP Holdings Inc., HMO Colorado Inc., HMO Missouri Inc., Health Core Inc., Health Management Corporation, Health Ventures Partner L.L.C., HealthKeepers Inc., HealthLink HMO Inc., HealthLink Inc., HealthLink Insurance Company, HealthPlus HP LLC, HealthSun Health Plans, HealthSun Health Plans Inc., HealthSun Holdings LLC, HealthSun Management LLC, HealthSun Physicians Network I LLC, HealthSun Physicians Network LLC, Healthy Alliance Life Insurance Company, Highland Acquisition Holdings LLC, Highland Holdco Inc., Highland Intermediate Holdings LLC, Highland Investor Holdings LLC, Imaging Management Holdings LLC, IngenioRx Inc., Legato Health Technologies LLP, Legato Health Technologies Philippines Inc., Legato Holdings I Inc., Legato Holdings II LLC, Living Complete Technologies Inc., Matthew Thornton Health Plan Inc., Memphis Supportive Care Partnership LLC, Meridian Resource Company LLC, Missouri Care Incorporated, NGS Federal LLC, Nash Holding Company LLC, National Government Services Inc., New England Research Institutes Inc., Optimum Healthcare Inc., Park Square Holdings Inc., Park Square I Inc., Park Square II Inc., Pasteur Medical Bird Road LLC, Pasteur Medical Center LLC, Pasteur Medical Cutler Bay LLC, Pasteur Medical Group LLC, Pasteur Medical Hialeah Gardens LLC, Pasteur Medical Holdings LLC, Pasteur Medical Kendall LLC, Pasteur Medical Management LLC, Pasteur Medical Miami Gardens LLC, Pasteur Medical North Miami Beach LLC, Pasteur Medical Partners LLC, Resolution Health Inc, Resolution Health Inc., RightCHOICE Managed Care Inc., Rocky Mountain Hospital and Medical Service Inc., SellCore Inc., Simply Healthcare Holdings, Simply Healthcare Plans Inc., Southeast Services Inc., State Sponsored DM Services Inc., The Anthem Companies Inc., The Anthem Companies of California Inc., TrustSolutions LLC, UNICARE Health Plan of West Virginia Inc., UNICARE Illinois Services Inc., UNICARE National Services Inc., UniCare Life & Health Insurance Company, UniCare Specialty Services Inc., Valus Inc., WPMI LLC, WellCare of Nebraska Inc., WellPoint Acquisition LLC, WellPoint California Services Inc., WellPoint Dental Services Inc., WellPoint Health Solutions Inc., WellPoint Holding Corp., WellPoint Information Technology Services Inc., WellPoint Insurance Services Inc., WellPoint Military Care Corporation, Wellmax Health Medical Centers LLC, Wellmax Health Physicians Network LLC, and Wisconsin Collaborative Insurance Company.
Read More
This page (NYSE:ELV) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners